Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Hexarelin Dosage Comparison by Research Application

Different research objectives within GH secretagogue studies require adjusted Hexarelin dosing strategies. The table below compares typical dose ranges, administration timing, and protocol duration for three common research frameworks. Acute GH Response Studie

This comparison does not assign a generated winner or score.

  • Different research objectives within GH secretagogue studies require adjusted Hexarelin dosing strategies. The table below compares typical dose ranges, administration timing, and protocol duration for three common research frameworks.
  • Acute GH Response Studies
  • 50–200mcg single dose
  • One-time or weekly intervals
  • Single dose to 4 weeks
  • 2mL reconstitution for precision in 50mcg increments
  • Best for establishing dose-response curves; single-dose design eliminates desensitization variables
  • Body Composition Research
  • 100–200mcg per dose
  • Twice daily (morning, pre-sleep)
  • 4–8 weeks on, 2 weeks off
  • 2–2.5mL reconstitution; calculate weekly usage × cycle length
  • Requires consistent timing; cyclical design preserves receptor sensitivity across multi-month studies
  • Cardioprotection/Tissue Studies
  • 100–150mcg per dose
  • Once or twice daily
  • 6–12 weeks continuous
  • 2mL standard; prioritize stable concentration over volume
  • Lower doses sufficient; focus on chronic low-level GH elevation rather than peak pulses
More references

Related material